 |
| 首頁 > 美迪醫訊 > Lipid Regulating Drugs and Anti-artherosclerosis Drugs Repor |
Lipid Regulating Drugs and Anti-artherosclerosis Drugs Repor 【?2008-08-05 發布?】 美迪醫訊
Lipid Regulating Drugs and Anti-artherosclerosis Drugs ReportMarket Research Report On Lipid Regulating Drugs and Anti-artherosclerosis Drugs
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: July 2006
Format: Hardcopy and Adobe PDF
Price: US$3,500
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
First part: Epidemiology of hyperlipemia
1 Conception of hyperlipemia
2 Types of hyperlipemia
3 Epidemiology of hyperlipemia in China
3.1 Chinese blood-lipid level and distribution feature
3.2 Morbidity rate
4 Catergories and product structure
5 Overview of Health food for lipids regulating
Second part: Market analysis
1 Market scale and growth trend of cardiovascular drugs
2 Overview about lipids regulating drugs marekt
2.1 Academic market capacity
2.2 Overview about hospital market and retail market
3 Analysis about hospital market
3.1 Growth trend of lipids regulating drugs in the past few years
3.2 Market shares of different categories
3.3 Sales rank of breeds of lipids regulating drugs last year
3.4 Sales analysis in key cities
3.5 Sales analysis of Statin drugs
3.5.1 Simvastatin(Zocor)
3.5.2 Lovastatin(Mevacor)
3.5.3 Pravastatin
3.5.4 Fluvastatin(Lescol)
3.5.5 Atorvastatin
3.5.6 Rosuvastatin
3.5.7 Compound preparation of Statins
ezetimibe/Simvastatin （Vytorin）
Torcetrapib/Atorvastatin
MK-0524A/Zocor
Statins+cholalic acid chelating agent
Other compound preparation of Statins
3.6 Fibrates
3.6.1 Fenofibrate
3.6.2 Gemfibrozil
3.7 Nicotinic Acid class
3.7.1 Tocopheryl Nicotinate
3.7.2 Acipimox
3.8 Prepared Chinese Medicine
3.8.1 "ZhiBiTuo"
3.8.2 "XueZhiKang"
3.8.3 Gypenosides
3.9 Heparins class
3.9.1 Chondroitin A
3.9.2 Alginic Sodium Diester
3.9.3 Mannose Ester
3.10 Polyunsaturated fatty acid class
3.10.1 Ethyl Polyenoate
3.10.2 Squalene
3.10.3 Linoleic acid compound
3.10.4 Evening primrose oil
3.11 Analysis about manufacturing enterprises
3.11.1 Market share of procucts made by domestic, foreign, joint venture enterprises
3.11.2 Top 15 manufacturing enterprising last year
4 Analysis about retail market
4.1 Market shares of different categories
4.2 Sales rank of breeds of lipids regulating drugs
4.3 Sales shares of different enterprises
4.3.1 Statins
4.3.2 Prepared Chinese Medicine
4.3.3 Fibrates
4.3.4 Polyunsaturated fatty acid class
4.3.5 Nicotinic Acid class
4.4 Enterprise list ranked by sales value
4.5 Top 15 enterpsies ranked by sales value in different cities
4.5.1 Beijing
4.5.2 Shanghai
4.5.3 Guangzhou
4.5.4 Wuhan
4.5.5 Shenyang
4.5.6 chengdu
4.5.7 hangzhou
4.5.8 Shenzhen
4.5.9 Shijiazhuang
4.5.10 Zhengzhou
本文關鍵字:
《美迪醫訊》歡迎您參與新聞投稿，業務咨詢： 美迪醫療網業務咨詢《上海醫療器械批發》產品推薦
|
| 合作支持：中華醫學會 | 中華醫院管理學會 | 國家食品藥品監督管理家用護理器械商城 | 國藥勵展展覽有限責任公 | 醫學裝備協會 |
| 刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關于美迪 | 法律聲明 | 隱私保護 | 網站地圖 |
| 把美迪網放進收藏夾 把美迪醫療網介紹給我的朋友 給美迪醫療網留言
美迪醫療網廣告業務聯系：021-51601230 產品咨詢業務聯系：021-51601230 傳真：021-56532303 
美迪醫療網業務咨詢
互聯網藥品信息服務許可證：(滬)-經營性-2009-0003 中華人民共和國電信與信息服務業務經營許可證：(滬)B2-20090029  滬ICP備14001091號-8  公安備案號 31010602000199 醫療器械經營許可證: 滬靜藥監械經營許20210003號 第二類醫療器械經營備案憑證: 滬靜藥監械經營備20220042號 營業執照:統一社會信用代碼91310108676284138X互聯網藥品信息服務資格書:(滬)-非經營性-2023-0081 |
.text:''):(d.getSelection?d.getSelection():'');void(keyit=window.open('http://my.poco.cn/fav/storeIt.php?t='+escape(d.title)+'&u='+escape(d.location.href)+'&c='+escape(t)+'&img=http://www.h-strong.com/blog/logo.gif','keyit','scrollbars=no,width=475,height=575,status=no,resizable=yes'));keyit.focus(); "添加到POCO網摘"){kind=logo}
